<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJNeph</journal-id><journal-title-group><journal-title>Open Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2164-2842</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojneph.2022.123029</article-id><article-id pub-id-type="publisher-id">OJNeph-119725</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Renal Failure of Lithiasis Origin: Frequency and Management in the Nephrology and Haemodialysis Department of the Point G University Hospital in Mali
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Seydou</surname><given-names>Sy</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Magara</surname><given-names>Samaké</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aboubacar</surname><given-names>Sidiki Fofana</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Atabieme</surname><given-names>Kodio</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Oligue</surname><given-names>Prudence Oman</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djibril</surname><given-names>Sy</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamadoun</surname><given-names>Yattara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djénèba</surname><given-names>Diallo</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sah</surname><given-names>Dit Baba Coulibaly</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nouhoum</surname><given-names>Coulibaly</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Modi</surname><given-names>Sidibé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alkaya</surname><given-names>Touré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moustapha</surname><given-names>Tangara</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Lamine Diakité</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Assétou</surname><given-names>Soukho Kaya</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Saharé</surname><given-names>Fongoro</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Nephrology and Hemodialysis Department, University Teaching Hospital of Point-G, Bamako, Mali</addr-line></aff><aff id="aff4"><addr-line>Faculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali</addr-line></aff><aff id="aff6"><addr-line>Department of Internal Medicine, University Teaching Hospital of Point-G, Bamako, Mali</addr-line></aff><aff id="aff5"><addr-line>Department of Urology, University Teaching Hospital of Point-G, Bamako, Mali</addr-line></aff><aff id="aff3"><addr-line>Nephrology Unit, Fousseyni Daou Hospital in Kayes, Kayes, Mali</addr-line></aff><aff id="aff2"><addr-line>National Center for Scientific and Technological Research (CNRST), Bamako, Mali</addr-line></aff><pub-date pub-type="epub"><day>28</day><month>07</month><year>2022</year></pub-date><volume>12</volume><issue>03</issue><fpage>276</fpage><lpage>292</lpage><history><date date-type="received"><day>7,</day>	<month>July</month>	<year>2022</year></date><date date-type="rev-recd"><day>6,</day>	<month>September</month>	<year>2022</year>	</date><date date-type="accepted"><day>9,</day>	<month>September</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: The term urinary lithiasis (UL) from the Greek “lithos” refers to the disease characterised by the result of abnormal precipitation of normal constituents of the urine within the urinary tract. The aim of this work was to determine the frequency of obstructive renal failure (ORF) of lithiasis origin and to describe the therapeutic indications. 
  Methods: This was a retrospective prospective study in patients hospitalised in the nephrology department of Point G University Hospital for ORF of lithiasis origin over a 26-month period from 1 January 2018 to 1 February 2020 inclusive. 
  Results: Among 1898 hospitalized patients, 32 met the inclusion criteria, 
  i.e.  a frequency of 1.7%. The male sex was 68.75% with a sex ratio of 2.2. The mean age was 48.38 &#177; 13.423 years with extremes of 20 and 65 years. Dysuria and urinary bilharzia were the main uro-nephrological antecedents, accounting for 25% of the cases each. Pain syndrome was the main functional sign, accounting for 100%. Ultrasound of the urinary tract (n = 28) showed stones in 92.85%. These stones were bilateral in 22.22% of cases. The dilatation was pyelocalic in 14 cases (51.8%). The uroscanner showed a pyelic location of the stones in both kidneys; 42.1% on the right and 33.3% on the left. Hydronephrosis was the most common dilatation: 37.8% on the right and 29.7% on the left. Renal lithiasis was complicated by acute kidney injury (ARI) in 17 cases (53.1%) versus 15 cases (46.9%) of chronic kidney disease (CKD). Urethral catheter was the means of drainage in 24 (75%) followed by nephrostomy in 8 cases (25%). Nephrolithotomy accounted for 9.4% of cases. The case fatality rate was 28.12% (9 cases). Deaths occurred in the context of uraemic coma 6 cases and cardiorespiratory arrest 3 cases. 
  Conclusions: The management of urinary lithiasis complicated by renal failure calls for the correction of hydrolytic disorders, drainage of the excretory tract and treatment of the stone, of which percutaneous nephrolithotomy seems to be the modality of choice.
 
</p></abstract><kwd-group><kwd>Renal Failure</kwd><kwd> Urinary Lithiasis</kwd><kwd> Nephrology</kwd><kwd> University Teaching Hospital of Point-G</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The term urinary lithiasis (UL) from the Greek “lithos” refers to the disease characterised by the result of abnormal precipitation of normal constituents of urine within the urinary tract [<xref ref-type="bibr" rid="scirp.119725-ref1">1</xref>]. It is a major public health problem that nephrologists and urologists are regularly confronted with because of the recurrent nature of the disease [<xref ref-type="bibr" rid="scirp.119725-ref2">2</xref>]. It is currently the most common urinary tract disease; almost 10% of men and 5% of women have suffered or will suffer from renal colic at least once in their lifetime [<xref ref-type="bibr" rid="scirp.119725-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.119725-ref3">3</xref>].</p><p>In the vast majority of cases, it is a painful and essentially benign condition, however some forms of UL can lead to impaired renal function which may require replacement therapy [<xref ref-type="bibr" rid="scirp.119725-ref4">4</xref>].</p><p>Imaging is used to confirm the positive diagnosis of UL, to assess its impact on the excretory tract and the renal parenchyma, and to contribute to the etiological investigation [<xref ref-type="bibr" rid="scirp.119725-ref5">5</xref>]. The search for lithogenic factors involves anamnestic investigation, analysis of the stone and/or urinary crystals, and blood and urine biology. This is essential if effective preventive measures against recurrence are to be proposed [<xref ref-type="bibr" rid="scirp.119725-ref6">6</xref>]. Surgical treatment has made considerable progress with percutaneous surgery, extracorporeal lithotripsy and endoscopic surgery. Although usually reversible, some lithiasis tends to recur, increasing the risk of renal failure [<xref ref-type="bibr" rid="scirp.119725-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.119725-ref6">6</xref>]. UL affects 10% - 12% of the French population and is responsible for 2% - 3% of the causes of end-stage renal disease (ESRD) [<xref ref-type="bibr" rid="scirp.119725-ref7">7</xref>]. In sub-Saharan Africa, ESRD of lithiasis origin is an important factor in hospital morbidity and mortality due to the severity of the underlying pathologies and the high incidence of complications [<xref ref-type="bibr" rid="scirp.119725-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.119725-ref9">9</xref>]. In Ivory Cost at Treichville University Hospital, from June 2010 to June 2014, upper urinary tract obstructions were responsible for fatal renal failure in 29.23% of cases [<xref ref-type="bibr" rid="scirp.119725-ref8">8</xref>]. The prevalence of obstructive renal failure (ORF) was 10.32% in Cotonou in 2017 and its causes were dominated by pelvic tumours and LU [<xref ref-type="bibr" rid="scirp.119725-ref9">9</xref>]. In Morocco, Zahra F [<xref ref-type="bibr" rid="scirp.119725-ref3">3</xref>] found 21% of renal failure cases of lithiasis origin.</p><p>In Mali, Diarra M [<xref ref-type="bibr" rid="scirp.119725-ref10">10</xref>] in his study in the urology department of the University Teaching Hospital of Kati found a frequency of ORF of 16.06%.</p><p>To our knowledge, there has been no study in Mali on ORF of lithiasis origin, hence the interest of this work which aimed to determine the frequency of ORF of lithiasis origin and to describe the therapeutic indications.</p></sec><sec id="s2"><title>2. Methodology</title><sec id="s2_1"><title>2.1. Type and Period of Study</title><p>This was a retrospective prospective study, spanning a period of 26 months from January 1, 2018 to February 1, 2020 concerning patients hospitalised in the Nephrology Department of the University Teaching Hospital of Point-G.</p></sec><sec id="s2_2"><title>2.2. Study Population</title><p>All patients hospitalised in the nephrology department for lithiasis-induced renal failure (RI) during the study period constituted our study population.</p><p>These patients were subdivided into four groups according to the presence of renal failure, the latter being defined by a plasma creatinine greater than 132.75 &#181;mol/l [<xref ref-type="bibr" rid="scirp.119725-ref11">11</xref>]:</p><p>- Group 1: patients with urinary calculi complicated by chronic kidney disease (CKD) without urinary tract infection (UTI).</p><p>- Group 2: patients with urinary calculi complicated by acute kidney injury (AKI) without UTI.</p><p>- Group 3: patients with urinary calculi complicated by CKD with UTI.</p><p>- Group 4: patients with urinary calculi complicated by AKI with UTI.</p></sec><sec id="s2_3"><title>2.3. Inclusion Criteria</title><p>Any patient with AKI or CKD hospitalised in the department whose cause was radiologically confirmed lithiasis.</p></sec><sec id="s2_4"><title>2.4. Non-Inclusion Criteria</title><p>- Presence of chronic/acute kidney disease or chronic/acute renal failure (CKD/ AKI) of non-lithiasis origin.</p><p>- Non-usable records.</p></sec><sec id="s2_5"><title>2.5. Data Collection and Analysis</title><p>Data were collected from the patient’s file and hospitalization register including surname, first name, age, date of entry, origin, complementary examinations, daily treatment, and evolution (see Annexes). The standards used for the biological examinations were those of the different analysis laboratories in Bamako.</p><p>Each patient in the series was given an individual survey form (after obtaining the consent of the patient or a close relative) which enabled us to collect data classified into qualitative and quantitative variables.</p><p>The data was entered using Microsoft Word 2010. Data analysis was done using SPSS 22.0 for Windows. The statistical tests used for the comparison of these categorical variables were Pearson’s Chi2 test and Fischer’s test of accuracy. The expected level of significance was p &lt; 0.05.</p></sec><sec id="s2_6"><title>2.6. Operational Definitions</title><p>Elderly: The world health organization (WHO) has defined an elderly person as anyone over the age of 65 years [<xref ref-type="bibr" rid="scirp.119725-ref12">12</xref>].</p><p>Acute renal failure: ARF is defined as a sudden and significant drop in glomerular filtration rate (GFR) that is usually reversible after treatment (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Chronic kidney disease: defined as a glomerular filtration rate (GFR) &lt; 60 ml/min/1.73m<sup>2</sup> for more than 3 months (<xref ref-type="table" rid="table2">Table 2</xref>).</p></sec></sec><sec id="s3"><title>3. Results</title><p>During the study period, 1898 patients were hospitalized in the nephrology department of Point G University Hospital, and 32 patients met the inclusion criteria, i.e. a prevalence of 1.7%.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Universal definition of acute renal failure according to KDIGO (Kidney Disease/Improving Global Outcome 2012)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >ARI stage</th><th align="center" valign="middle" >Cr&#233;atinine</th><th align="center" valign="middle" >Diuresis</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Increase &gt; 26 μmol/L (3 mg/L) in 48 h or &gt;50% in 7 days</td><td align="center" valign="middle" >&lt;0.5 ml/kg/h for 6 to 12 hours</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Creatinine &#215; 2 &lt; 0.5 ml/kg/h ≥ 12 h</td><td align="center" valign="middle" >Creatinine &#215; 2 &lt; 0.5 ml/kg/h ≥ 12 h</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >Creatinine &#215; 3 or Creatinine &gt; 354 μmol/L (40 mg/L) if no previous value or need for dialysis</td><td align="center" valign="middle" >&lt;0.3 ml/kg/h ≥ 24 h or anuria ≥ 12 h</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Modification diet in renal desease (MDRD) stage of chronic kidney disease</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Stages</th><th align="center" valign="middle" >Description</th><th align="center" valign="middle" >GFR (ml/min/1.73m<sup>2</sup>)</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >CKD* with normal renal function</td><td align="center" valign="middle" >≥90</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >CKD* with mild renal failure</td><td align="center" valign="middle" >60 - 89</td></tr><tr><td align="center" valign="middle" >3A</td><td align="center" valign="middle" >Moderate renal failure</td><td align="center" valign="middle" >45 - 59</td></tr><tr><td align="center" valign="middle" >3B</td><td align="center" valign="middle" >Moderate renal failure</td><td align="center" valign="middle" >30 - 44</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >severe renal failure</td><td align="center" valign="middle" >15 - 29</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >End-stage renal failure</td><td align="center" valign="middle" >&lt;15</td></tr></tbody></table></table-wrap><p>*With markers of renal impairment: clinical proteinuria, haematuria, leucocyturia, or morphological or histological abnormalities or markers of tubular dysfunction, persisting for more than 3 months.</p><p>The male sex was 68.75% (22 cases), i.e. a sex ratio of 2.2. The age group 40 - 59 was the most represented, i.e. 43.75 (14 cases) with an average age of 48.38 &#177; 13.423 years and extremes of 20 and 65 years (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Hypercreatinemia was the main reason for consultation, 62.5% or 20 cases (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>According to MDRD, end-stage renal disease accounted for 28.1% of patients (28.1 cases). Hypertension was the main associated condition, 43.75% (14 cases). Dysuria and urinary bilharzia were the main uro-nephrological antecedents, each accounting for 25% (8 cases).</p><p>Physical asthenia and algic syndrome were the main clinical signs, accounting for 75% (24 cases) and 100% respectively (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>Symptoms related to uraemia were anorexia (71.9%), vomiting (68.8%), nausea (62.5%), and insomnia (21.9%).</p><p>The physical examination showed oedema of the lower limbs in 75% of the patients (24 cases) (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>Arterial hypertension (AH) was observed in 40.6% (13 cases) with a mean blood pressure of 143.19/89.66 mmHg, extremes of 240 and 70 mmHg for systole and 150 and 40 mmHg for diastole. WHO grade 3 hypertension accounted for 53.8% of the 13 hypertensive patients.</p><p>On renal ultrasound (n = 28), urinary stones were found in 92.85% (26 cases). They were bilateral in 22.22% of cases. The dilatation was pyelocalic in 51.8% (14 cases).</p><p>The uroscanner performed in 20 patients showed a pyelic location of the stones in both kidneys; 42.1% (8 cases) on the right and 33.3% (6 cases) on the left.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of patients by age group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Age range</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent (%)</th></tr></thead><tr><td align="center" valign="middle" >20 - 39</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >31.25</td></tr><tr><td align="center" valign="middle" >40 - 59</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >43.75</td></tr><tr><td align="center" valign="middle" >≥ 60</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Breakdown by reason for consultation</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Reasons for consulting</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent (%)</th></tr></thead><tr><td align="center" valign="middle" >Increase in creatinine</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >62.5</td></tr><tr><td align="center" valign="middle" >Renal distress on ultrasound</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >15.6</td></tr><tr><td align="center" valign="middle" >Renal colic</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >9.4</td></tr><tr><td align="center" valign="middle" >Oedematous syndrome</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.25</td></tr><tr><td align="center" valign="middle" >Polycystic kidney disease</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.125</td></tr><tr><td align="center" valign="middle" >Headache</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.125</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >100,0</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution according to clinicals signs</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >clinicals signs</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent (%)</th></tr></thead><tr><td align="center" valign="middle"  rowspan="6"  >General signs</td><td align="center" valign="middle" >Physical asthenia</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >75.0</td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >62.5</td></tr><tr><td align="center" valign="middle" >Weight loss</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >56.3</td></tr><tr><td align="center" valign="middle" >Conjunctival heat</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >53.1</td></tr><tr><td align="center" valign="middle" >High blood pressure</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >40.6</td></tr><tr><td align="center" valign="middle" >Extrarenal dehydration</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >28.1</td></tr><tr><td align="center" valign="middle"  rowspan="17"  >Fonctional signs</td><td align="center" valign="middle" >Pain syndrome*</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Anorexia</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >71.9</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >68.8</td></tr><tr><td align="center" valign="middle" >Nausea</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >62.5</td></tr><tr><td align="center" valign="middle" >Dizziness</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >43.8</td></tr><tr><td align="center" valign="middle" >Headache</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >40.6</td></tr><tr><td align="center" valign="middle" >Dysuria</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >37.5</td></tr><tr><td align="center" valign="middle" >Dyspnea</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >37.5</td></tr><tr><td align="center" valign="middle" >Hematuria</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >34.4</td></tr><tr><td align="center" valign="middle" >Burning of the bladder</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >31.3</td></tr><tr><td align="center" valign="middle" >Insomnia</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >21.9</td></tr><tr><td align="center" valign="middle" >Tinnitus</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >21.9</td></tr><tr><td align="center" valign="middle" >Abdominal distension</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >18.8</td></tr><tr><td align="center" valign="middle" >Visual blur</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >15.6</td></tr><tr><td align="center" valign="middle" >Pollakiuria</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >12.5</td></tr><tr><td align="center" valign="middle" >Diarrhoea</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >12.5</td></tr><tr><td align="center" valign="middle" >Anuria</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.3</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >Physical signs</td><td align="center" valign="middle" >Edema</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >75.0</td></tr><tr><td align="center" valign="middle" >Tachycardia</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >34.4</td></tr><tr><td align="center" valign="middle" >Lumbar contact</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >18.8</td></tr><tr><td align="center" valign="middle" >Abdominal distension</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >12.5</td></tr><tr><td align="center" valign="middle" >Abdominal pelvic mass</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >12.5</td></tr></tbody></table></table-wrap><p>*Pain syndrome: renal colic, low back pain, hypogastric pain.</p><p>Hydronephrosis was the most common dilatation: 37.8% (14 cases) on the right and 29.7% (11 cases) on the left (<xref ref-type="table" rid="table6">Table 6</xref>).</p><p>End-stage renal failure was observed in 09 cases (28.1%) and the mean creatinemia was 598.15 &#181;mol/l, with extremes from 160 &#181;mol/l to 2309 &#181;mol/l.</p><p>Anemia was found in 89.3% of patients (25 cases) with a mean hemoglobin level of 9.3 g/dl and extremes ranging from 4 g/dl to 16.10 g/dl. It was normocytic normochromic in 44% of cases and aregenerative in 88.9% of cases.</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Impact of calculus on the cortical index of the kidney on computed tomography</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Impact on the cortical index</th><th align="center" valign="middle"  colspan="2"  >Kidney</th></tr></thead><tr><td align="center" valign="middle" >Rith (n = 19)</td><td align="center" valign="middle" >Left (n = 18)</td></tr><tr><td align="center" valign="middle" >Hydronephrosis</td><td align="center" valign="middle" >14 (37.8%)</td><td align="center" valign="middle" >11 (29.7%)</td></tr><tr><td align="center" valign="middle" >Ureteral dilatation</td><td align="center" valign="middle" >3 (8.1%)</td><td align="center" valign="middle" >3 (8.2%)</td></tr><tr><td align="center" valign="middle" >Uretero hydronephrosis</td><td align="center" valign="middle" >2 (5.4%)</td><td align="center" valign="middle" >4 (10.8%)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >19 (51.35%)</td><td align="center" valign="middle" >18 (48.64%)</td></tr></tbody></table></table-wrap><p>Hypocalcaemia and hyperphosphaemia were present in 34.4% and 37.5% of cases respectively. Hypovitaminosis D (n = 13) represented 61.5% or 5 cases. Parathyroid hormone (PTH, n = 13) was increased in 69.23% of patients (9 cases). The mean PTH was 297.54 pg/ml with extremes of 14.69 and 1895.70 pg/ml.</p><p>Proteinuria (n = 22) was minimal in 77.3% of cases (17 cases). Leukocyturia (n = 24) was found in 15 cases and associated with haematuria in 7 cases (33.3%).</p><p>Uraculture (n = 24) was positive in 58.3% (14 cases) with Escherichia coli as the most frequent germ (50%). Thus group 1 of the patients represented 60% (9 cases), group 2 52.9% (9 cases), group 3 40.6% (6 cases), group 4 47.1% (8 cases) (<xref ref-type="table" rid="table7">Table 7</xref>).</p><p>Renal lithiasis was complicated by AKI in 17 cases (53.1%) and CKD in 15 cases (46.9%).</p><p>Urethral catheterisation was the means of drainage in 24 cases (75%) followed by 8 cases of nephrostomy (25%). Nephrolithotomy accounted for 9.4% of cases. The three cases of nephrolithotomy were performed only in CKD patients.</p><p>Medical treatment consisted of analgesics and antispasmodics in 100% of cases. Antibiotic therapy was used in 96.9% of patients (31 cases).</p><p>Renal replacement therapy by haemodialysis was initiated in 12 patients (37.5%). The indications for dialysis were uraemic syndrome (05 cases), hyperkalaemia (2 cases), acute lung oedema (03 cases) and pre-operatively (2 cases).</p><p>The outcome was favourable in 14 cases (<xref ref-type="table" rid="table8">Table 8</xref>). The case fatality rate was 28.12 (09 cases). The causes of death were uraemic coma (06 cases) and cardiorespiratory arrest (03 cases).</p></sec><sec id="s4"><title>4. Comments and Discussion</title><sec id="s4_1"><title>4.1. Frequency</title><p>At the end of our study, 32 patients out of 1898 hospitalizations were treated for lithiasis-induced OFR, i.e. a prevalence of 1.7%.</p><p>There are very few published studies on the development of renal failure in patients with UL. However, the occurrence of renal failure in patients with UL remains a fairly common complication [<xref ref-type="bibr" rid="scirp.119725-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.119725-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.119725-ref14">14</xref>]. Some authors have found similar results such as Gupta et al. [<xref ref-type="bibr" rid="scirp.119725-ref15">15</xref>] 1.7%; Kukreja et al. [<xref ref-type="bibr" rid="scirp.119725-ref16">16</xref>] 1.8%.</p><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Distribution of the type of renal failure according to the urinary infection</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Type of renal failure</th><th align="center" valign="middle"  colspan="2"  >urinary infection</th><th align="center" valign="middle"  rowspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >No</td></tr><tr><td align="center" valign="middle" >Lithiasis complicated by AKI</td><td align="center" valign="middle" >8 (47.1%)</td><td align="center" valign="middle" >9 (52.9%)</td><td align="center" valign="middle" >17 (53.1%)</td></tr><tr><td align="center" valign="middle" >Lithiasis complicated by CKD</td><td align="center" valign="middle" >6 (40%)</td><td align="center" valign="middle" >9 (60%)</td><td align="center" valign="middle" >15 (46.9%)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >14 (43.8%)</td><td align="center" valign="middle" >18 (56.2%)</td><td align="center" valign="middle" >32 (100%)</td></tr></tbody></table></table-wrap><p>Chi-square = 0.161; ddl = 1; p = 0.688.</p><table-wrap id="table8" ><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> Distribution according to the evolution of the patient</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >&#201;volution</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent (%)</th></tr></thead><tr><td align="center" valign="middle" >favourable</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >43.8</td></tr><tr><td align="center" valign="middle" >Deaths</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >28.1</td></tr><tr><td align="center" valign="middle" >lost sight of</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >9.4</td></tr><tr><td align="center" valign="middle" >Discharged against medical advice</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >18.7</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap></sec><sec id="s4_2"><title>4.2. Socio-Demographic Data</title><p>The mean age of our patients was 48.38 &#177; 13.423. The age of discovery of lithiasis in our series varied from 20 to 59 years. Studies by Daudon M [<xref ref-type="bibr" rid="scirp.119725-ref17">17</xref>], on the evolution of urinary lithiasis according to age, have shown the appearance of the first stone with a significant spread of the frequency peak between 30 and 55 years of age in both sexes. These results show that the age group frequently affected by urinary lithiasis is between the 3rd and 6th decade. This leads to the conclusion that many urinary tract infections occur during periods of genital and social activity, which draws attention to urogenital infections.</p><p>The male gender was predominantly with a sex ratio of 2.2 in favour of men.</p><p>The male predominance can be explained by the multiplicity of organic factors that can favour lithogenesis (prostate hypertrophy, urethral strictures) [<xref ref-type="bibr" rid="scirp.119725-ref18">18</xref>].</p></sec><sec id="s4_3"><title>4.3. Clinical Characteristics</title><p>All the patients in our study were referred by the health structures for nephrological consultation, the main reason being an increase in creatinemia, which accounted for 62.5% of the patients (20 patients).</p><p>High blood pressure was the most frequent morbid association (40.6%). Our rate is much higher than that of Zahra F [<xref ref-type="bibr" rid="scirp.119725-ref3">3</xref>] (8.5%). This high frequency could be explained by a late nephrological consultation on the one hand and on the other hand through ageing leading to an increase in arterial stiffness by replacement of collagen by elastic fibres [<xref ref-type="bibr" rid="scirp.119725-ref19">19</xref>].</p><p>On the uro-nephrological level, urinary bilharziasis was found in 8 patients, i.e. 25% of cases, compared with 46.5% for Ongoiba I [<xref ref-type="bibr" rid="scirp.119725-ref19">19</xref>]; 48.6% for Demb&#233;l&#233; Z [<xref ref-type="bibr" rid="scirp.119725-ref20">20</xref>]; and 41.6% for Keita. O [<xref ref-type="bibr" rid="scirp.119725-ref21">21</xref>].</p><p>These high frequencies testify to the endemic nature of urinary bilharziasis and demonstrate its role in lithogenesis through inflammation and fibrosis of the urinary tract, which leads to urinary stasis that favours the formation of urinary stones. Its low frequency in this study could be explained by the intensification of mass campaigns for the management of neglected tropical diseases in recent decades [<xref ref-type="bibr" rid="scirp.119725-ref22">22</xref>].</p><p>With regard to clinical symptoms, pain was the first revealing sign (90.62%) and anuria (6.2%). The series by Zahra F [<xref ref-type="bibr" rid="scirp.119725-ref3">3</xref>] also found pain to be the first revealing manifestation with a frequency of 95.4%; on the other hand, Agrawal et al. [<xref ref-type="bibr" rid="scirp.119725-ref23">23</xref>] found that the two main reasons for consultations leading to the diagnosis of renal failure of lithiasis origin were anuria and incidental discovery as part of a standard workup when the patients were totally asymptomatic.</p><p>However, most of our patients came to the clinic in the end stage with a manifest uraemic syndrome (physical asthenia, anorexia, vomiting, nausea, and insomnia).</p><p>On physical assessment, lumbar contact was found in 18.8% of our patients. This frequency is similar to that of Zahra F [<xref ref-type="bibr" rid="scirp.119725-ref3">3</xref>] who reported 15.3% of cases.</p></sec><sec id="s4_4"><title>4.4. Paraclinical Data</title><sec id="s4_4_1"><title>4.4.1. Medical Imaging Data</title><p>Ultrasound of the urinary tract and computed tomography (CT) were the medical imaging examinations performed with 87.5% and 62.5% respectively [<xref ref-type="bibr" rid="scirp.119725-ref24">24</xref>].</p><p>Ultrasound in 28 patients showed UL in 100% of cases and pyelocal dilatation in 92.85% of cases.</p><p>In the study by Zahra F [<xref ref-type="bibr" rid="scirp.119725-ref3">3</xref>], ultrasound found lithiasis in 73.9% and pyelocal dilatation in 69.2%.</p><p>CT, having benefited from helical acquisition, seems to be the imaging examination with the best sensitivity and specificity [<xref ref-type="bibr" rid="scirp.119725-ref24">24</xref>].</p><p>Uroscans were performed in 62.5% of our patients (20 cases). A single left kidney was found. Hydronephrosis was found in 37.8% on the right and 29.7% on the left; the latter was the most frequent dilatation.</p></sec><sec id="s4_4_2"><title>4.4.2. Biological Data</title><p>The mean creatinine level was 598.15 &#181;mol/l with extremes of 160 &#181;mol/l and 2309 &#181;mol/l. A lower mean was observed in the series of Allod&#233; AS et al. in benign [<xref ref-type="bibr" rid="scirp.119725-ref25">25</xref>] 152.5 &#181;mol/l with extremes of 128.5 &#181;mol/l and 2159.6 &#181;mol/l. This high rate was probably related to a delay in diagnosis.</p><p>In our series, anaemia was present in 89.3% of cases. It was severe in 7.2% of cases. The mean haemoglobin level was 9 g/dl with extremes ranging from 4 to 16.10 g/dl. Age and advanced stage of chronic kidney disease may explain this high frequency of anaemia [<xref ref-type="bibr" rid="scirp.119725-ref26">26</xref>]. Zahra F [<xref ref-type="bibr" rid="scirp.119725-ref3">3</xref>] reported a lower frequency of anaemia in her study, 69.1%.</p><p>On uroculture, Escherichia coli was the most frequent germ (50%). In the series by Demb&#233;l&#233; M [<xref ref-type="bibr" rid="scirp.119725-ref27">27</xref>], the dominant germ was Enterococcus sp. with 13%.</p><p>In Mali, Demb&#233;l&#233; Z [<xref ref-type="bibr" rid="scirp.119725-ref20">20</xref>] found a urinary tract infection in 35.2% and 42.9% of cases respectively. This shows that UTI is frequently associated with urinary tract infections. The UTI may be secondary to the stone or to a foreign body (JJ catheter, nephrostomy). Endo urological manoeuvres for calculi significantly increase the risk of UTI, mainly Escherichia coli and Proteus mirabilis. While the germs of stones secondary to infection are in more than 55% of cases Proteus or Pseudomonas [<xref ref-type="bibr" rid="scirp.119725-ref28">28</xref>].</p></sec></sec><sec id="s4_5"><title>4.5. Management of UL Complicated by Renal Failure</title><p>Correction of metabolic disorders constituted treatment of hyperkalaemia in 2 patients by emergency management with haemodialysis. Of the 24 patients (75%) with fluid overload, the three patients with acute lung edema received emergency haemodialysis.</p><p>With regard to surgical treatment. Urine drainage is essential. When the obstruction is acute, it must be carried out urgently because there is a risk of infection of the overlying urine, causing acute obstructive pyelonephritis [<xref ref-type="bibr" rid="scirp.119725-ref28">28</xref>].</p><p>In our series, urinary drainage was performed in all our cases, i.e. 100%:</p><p>The placement of a simple urethral catheter was effective in 24 cases (75%) versus 8 cases of nephrotomy (25%). Our result is different from those of Abaydi A et al. [<xref ref-type="bibr" rid="scirp.119725-ref29">29</xref>] in whom the double urethral catheter was used as internal urinary drainage in 82.7% of cases.</p><p>In the literature, nephrostomy seems to be the modality of choice for drainage of the excretory tract in lithiasis patients with renal faillure, it allows to improve renal function and the results of treatment of UL thus decreasing the recourse to dialysis and renal transplantation [<xref ref-type="bibr" rid="scirp.119725-ref30">30</xref>].</p><p>In this study, only three patients were able to undergo nephrolithotomy, i.e. 9.4% of cases. In the postoperative evolution, an improvement in renal function was noted in all three patients. These three patients had benefited from a nephrostomy long before and all had chronic kidney disease. Hyams et al. have shown that nephrolithotomy is effective and does not lead to deterioration of renal function [<xref ref-type="bibr" rid="scirp.119725-ref31">31</xref>].</p></sec><sec id="s4_6"><title>4.6. Evolution</title><p>In our series, the evolution was favorable in 43.75% of cases versus 81.5% for Zahra F [<xref ref-type="bibr" rid="scirp.119725-ref3">3</xref>]. Most of our patients had a low socio-economic level, which had an unfavorable impact on the early diagnosis and rapid management of the disease.</p><p>Patients with CKD of lithiasis origin had a favorable evolution compared to those with AKI, respectively 28.125% (9 cases) versus 15.62% (5 cases).</p><p>There was no significant relationship (P = 0.392) between outcome and type of renal failure.</p><p>The case fatality rate was 28.125% of cases, which is significantly lower than that of Lengani A et al. [<xref ref-type="bibr" rid="scirp.119725-ref32">32</xref>] in Burkina Faso where it was 44.2%. The two causes of death were, in order of frequency, uraemic coma (66.7%) and cardiorespiratory arrest (33.3%).</p></sec></sec><sec id="s5"><title>5. Limitations of the Study</title><p>In the course of our work we encountered limitations including:</p><p>- The very low socio-economic level of the patients.</p><p>- The files could not be used due to incomplete assessment.</p><p>- Lack of analysis of the lithiasis.</p></sec><sec id="s6"><title>6. Conclusions</title><p>The management of urinary lithiasis complicated by renal failure calls for the correction of hydrolytic disorders, drainage of the excretory tract and treatment of the stone, of which percutaneous nephrolithotomy seems to be the modality of choice.</p><p>It is a relatively easily curable condition, especially with the advent of endourology, although some conditions require open surgery. The lack of financial means for patients is a barrier to better management.</p></sec><sec id="s7"><title>Acknowledgements</title><p>Our greetings go out to all the staff of the nephrology department, the urology department and the medicine department of the Point G University Hospital.</p></sec><sec id="s8"><title>Authors’ Contributions</title><p>Seydou Sy, Magara Samak&#233;, Aboubacar Sidiki Fofana, Oligue Prudence Oman, Sahar&#233; Fongoro, Mamadou Lamine Diakit&#233; participated starting from proposal development, data collection, data entry and analysis, result write-up and interpretation, and manuscript preparation. All authors read and approved the final manuscript.</p></sec><sec id="s9"><title>Availability of Data and Materials</title><p>The databases used for this study are available from the corresponding author on reasonable request.</p></sec><sec id="s10"><title>Declarations</title>Ethics Approval and Consent to Participate<p>Free and informed consent was obtained before proceeding with the survey. Respect for anonymity was taken into consideration during data collection. The exploitation of the files was done after agreement of the head of the nephrology and haemodialysis department of the University Teaching Hospital of Point-G.</p>Consent for Publication<p>The authors state that the study is original, has not been published in any other journal and consents to its publication by this journal.</p></sec><sec id="s11"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s12"><title>Cite this paper</title><p>Sy, S., Samak&#233;, M., Fofana, A.S., Kodio, A., Oman, O.P., Sy, D., Yattara, H., Diallo, D., Coulibaly, S.D.B., Coulibaly, N., Sidib&#233;, M., Tour&#233;, A., Tangara, M., Diakit&#233;, M.L., Kaya, A.S. and Fongoro, S. (2022) Renal Failure of Lithiasis Origin: Frequency and Management in the Nephrology and Haemodialysis Department of the Point G University Hospital in Mali. Open Journal of Nephrology, 12, 276-292. https://doi.org/10.4236/ojneph.2022.123029</p></sec><sec id="s13"><title>Abbreviations</title><p>UL: urinary lithiasis,</p><p>ORF: obstructive renal failure,</p><p>AKI: acute kidney injury,</p><p>CKD: chronic kidney disease,</p><p>ESRD: end-stage renal disease,</p><p>UTI: urinary tract infection,</p><p>MDRD: modification diet in renal disease,</p><p>WHO: world health organization,</p><p>CT: computed tomography.</p></sec><sec id="s14"><title>Annexes</title><p>Survey form</p><p>IDENTITY</p><p>Age.......................................... Sexe..................................................</p><p>Origin........................................... Date of entry: .......................................</p><p>Entry number...................... Exit date: .......................................</p><p>Order number: .........................................</p><p>REASONS FOR HOSPITALISATION</p><p>Increased creatinemia ☐ Anuria ☐ Oedema syndrome ☐ Pyuria ☐</p><p>Ultrasound renal distress Proteinuria ☐ Haematuria ☐ Others....</p><p>HISTORY</p><p>Renal colic ☐ Low back pain ☐ Macroscopic hematuria ☐ Dysuria ☐</p><p>Burning of the bladder ☐ Pollakiuria ☐ Spontaneous stone removal ☐</p><p>Intervention for urinary lithiasis ☐ Recurrent urinary tract infection ☐</p><p>Urinary bilharzia ☐ Hyperparathyroidism ☐ Use of lithogenic drugs ☐</p><p>Malformative uropathy ☐ Neurological bladder ☐ Diabetes ☐</p><p>Hypertension ☐ Pathological creatinemia ☐ Oedematous syndrome ☐</p><p>Family history of lithiasis ☐ Leukaemia ☐ Gastro-duodenal ulcer ☐</p><p>Tuberculosis ☐ Vesico-vaginal fistula ☐ Others to be specified..................</p><p>FUNCTIONAL SIGNS:</p><p>Renal colic ☐ Low back pain ☐ Iliac fossa pain ☐ Hypogastric pain ☐</p><p>Haematuria ☐ Dysuria ☐ Spontaneous stone removal ☐</p><p>Fever ☐ Pyuria ☐ Pollakiuria ☐ Acute retention of urine ☐</p><p>Urinary urgency ☐ Anuria ☐ Oliguria ☐ Incontinence ☐</p><p>Urinary tract infection ☐ Acute renal failure ☐ Chronic renal failure ☐</p><p>Nausea + vomiting ☐ Diarrhoea ☐ abdominal distension ☐</p><p>Anorexia + weight loss ☐ Physical asthenia ☐ Muscle cramps ☐</p><p>Headaches ☐ Tinnitus ☐ Visual blur ☐ Dizziness ☐</p><p>Dyspnea ☐ Haemoptysis ☐ Haematemesis ☐ Chest pain ☐</p><p>Melena ☐ Cough ☐ Incidental findings ☐</p><p>PHYSICAL SIGNS</p><p>Blood pressure……. Temperature………. heart rate…… respiratory rate……</p><p>Height: ................... Weight: ..................... BMI: ……………….</p><p>Altered general condition ☐</p><p>Conjunctival pallor ☐ Edema ☐ Dry mouth ☐ Uremic glutens ☐</p><p>Icterus ☐ Dehydration folds ☐ stomatitis parotitis ☐</p><p>Cardiovascular examination: Normal ☐ Abnormal ……….</p><p>Lung examination: Normal ☐ Abnormal …………..</p><p>Other examinations:……………..</p><p>Abdominal scarring ☐ abdominal distension ☐ Bladder globe ☐</p><p>palpable pelvic mass ☐ Palpable abdominal mass ☐</p><p>prostatic hypertrophy ☐ cervical cancer ☐ flank tenderness ☐</p><p>lumbar contact ☐ large kidneys ☐ ascites ☐ splenomegaly ☐</p><p>hepatomegaly ☐ adenopathy ☐ muscle amyotrophy ☐ bone pain ☐</p><p>arthralgia ☐ polyneuritis ☐ state of consciousness ☐</p><p>PARACLINICAL EXAMINATIONS</p><p>1) RADIOLOGICAL:</p><p>Urinary tract ultrasound information: …………………………………………</p><p>Intravenous Urography informations: …………………………………………</p><p>urological scanner informations: ………………………………………………</p><p>cardiac ultrasound informations: ………………………………………………</p><p>electrocardiogram informations: ………………………………………………</p><p>2) BLOOD:</p><p>*creatinemia:/............................../.</p><p>GFR according to MDRD/........................./1 = Mild CKD (≥90); 2 = Mild CKD (60 - 89); 3 = Moderate CKD (30 - 59); 4 = Severe CKD (15 - 29); 5 = Terminal CKD ('15)</p><p>GFR according to COCKROFT-GAULT:/............./ GFR CKDEPI /.............../</p><p>*uric acid/................./normal (1) decreased (2) increased (3) value: ................. *urea/................/normal (1) decreased (2) increased (3) value: ............ *blood glucose/................/1 = normal (2.5 - 2.6) 2 = decreased (&lt;2.1) increased (&gt;2.6) value: ........</p><p>*blood phosphorus/............/1 = normal (0.8 - 1.45) 2 = decreased (&lt;0.8) increased (&gt;1.45) value: ............</p><p>*Vit D rate /............/normal (1) decreased (2) increased (3) value: ............</p><p>*PTH /............/normal (1) decreased (2) increased (3) value: ............ *natremia/............/1 = normal (135 - 145) 2 = decreased (&lt;135) increased (&gt;145) value:.....................</p><p>*kalaemia/...../normal (1) decreased (2) increased (3) value: ...........</p><p>- Blood count:</p><p>Anaemia yes no if yes</p><p>Hemoglobin level in g/dl /............/; /............/1 = normocytic; 2 = microcytic; 3 = macrocytic /................/1 = normochromic; 2 = hypochromic</p><p>/................/ 1 = regenerative; 2 = aregenerative</p><p>white blood cells/........../1 = normale (4000 - 10,000) 2 = diminu&#233; (&lt;4000)</p><p>value: ............</p><p>Platelet /............/1 = normale (150,000 - 400,000) increased (&gt;400,000) value:............</p><p>ferritinemia /............/ saturation coefficient /............%./ serial iron/............/</p><p>Interpretation.............................</p><p>fat balance/............/ 1 = normal; 2 = disturbed albuminemia/............/normal (1) decreased (2) increased (3) value: ............ *blood glucose/............/normal (1) decreased (2) increased (3) value: ............ *blood glucose/............/normal (1) decreased (2) increased (3) value: ............ glycated haemoglobin /............/normal (1) decreased (2) increased (3) value: ............</p><p>- urinary:</p><p>Urine sediment: haematuria (≥10,000/ml) yes/no, leucocyturia (≥10,000/ml) yes/no</p><p>pyuria yes/no culture/............/ 1 = positive; 2 = negative</p><p>if positive the germ:......................................</p><p>24 H proteinuria/............/ 1 = nothing; 2 = minimal (&lt;1 g); 3 = moderate (1 - 3 g); 4 = massive (&gt;3 g) value: ............</p><p>Natriuresis /................/normal (1) decreased (2) increased (3) value: ............</p><p>kaliuresis: /................/normal (1) decreased (2) increased (3) value: ............ Natriuresis/Kaliuresis ratio: ....................................</p><p>Other balances...........................................................</p><p>crystals: .......................</p><p>DIAGNOSIS:</p><p>*AKI on urinary lithiasis/................/ *CKD on urinary lithiasis/................/</p><p>*URINARY INFECTION on urinary lithiasis/......................../</p><p>MANAGEMENT:</p><p>1) Surgical:</p><p>simple urinary catheterisation ☐ nephrostomy pre-cutaneous ☐ nephrolithotomy ☐</p><p> If yes number of sessions........................................................................</p><p>- Extracorporeal lithotripsy ☐ yes/no Number of sessions................</p><p>- ureteroscopy ☐ yes/no</p><p>- pyelolithotomy ☐ total nephrectomy ☐ Partial nephrectomie ☐</p><p>- Open surgery:</p><p>*approach: ................................... *nephrolithotomy ☐ - ureterolithotomy ☐</p><p>- Treatment of a malformation or associated pathology ☐</p><p>-Laparoscopy ☐</p><p>*gesture performed</p><p>- Nephrectomy bladder size ☐ nephrolithotomy bladder size ☐ - pyelolithotomy bladder size ☐ - ureterolithotomy bladder size ☐ bladder size ☐</p><p>2) Medical:</p><p>analgesic alone ☐</p><p>antibiotic ☐</p><p>urine acidification ☐</p><p>replacement therapy ☐</p><p>If yes: pre-operative haemodialysis ☐ post-operative haemodialysis ☐</p><p>peritoneal dialysis</p><p>EVOLUTION:</p><p>1) Immediate postoperative:</p><p>clinical signs: Improvement of symptoms ☐ Persistence of symptoms ☐</p><p>renal function:</p><p>improvement worsening stabilisation</p><p>Complication</p><p>2) In the long term</p><p>clinical signs:</p><p>improvement of symptoms</p><p>renal function:</p><p>improvement ☐</p><p>worsening ☐</p><p>stabilization ☐</p></sec></body><back><ref-list><title>References</title><ref id="scirp.119725-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Moulin, B. and Peraldi, M.N. (2016) Néphrologie. 7ième édition, Ellipses, Paris.</mixed-citation></ref><ref id="scirp.119725-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Daudon, M., Traxer, O. and Jungers, P. (2012) Lithiase urinaire. 2e éd. Médecine-Sciences, Lavoisier, Paris.</mixed-citation></ref><ref id="scirp.119725-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Zahra, F. (2010) Insuffisance rénale d’origine lithiasique: Fréquence, facteurs prédictifs et prise en charge [Thèse Med]. Universite Cadi Ayyad, Marrakech, No. 29, 70-110.</mixed-citation></ref><ref id="scirp.119725-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Jungers, P., Joly, D., Barbey, F., Choukroun, G. and Daudon, M. (2005) Nephrolithiasis Induced End Stage Renal Disease: Frequency, Causes and Prevention. Néphrologie &amp; Thérapeutique, 1, 301-310. https://doi.org/10.1016/j.nephro.2005.08.001</mixed-citation></ref><ref id="scirp.119725-ref5"><label>5</label><mixed-citation publication-type="book" xlink:type="simple">Kourilsky, O. (2001) Lithise rénale. In: Kanfer, A., Kourilsky, O., Peraldi, M.-N. and Combe, C., Eds., Néphrologie et troubles hydroélectrolytiques, 3 e édition, Masson, Paris, 457.</mixed-citation></ref><ref id="scirp.119725-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Courbebaisse, M. and Daudon, M. (2017) Lithiase rénale et néphrocalcinose. In: Traité de néphrologie, E Thervet, Paris, 734.</mixed-citation></ref><ref id="scirp.119725-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">T&amp;uuml;rk, C., Petrik, A., et al. (2016) EAU Guidelines on Interventional Treatment for Urolithiasis. European Urology, 69, 475-482. https://www.sciencedirect.com/science/article/pii/S0302283815007009</mixed-citation></ref><ref id="scirp.119725-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Hamdi, A., Hajage, D., Van Gkabeke, E., Belenfant, X., Vincent, F., Gonzalez, F., et al. (2012) Severe Post-Renal Acute Kidney Injury, Post-Obstructive Diuresis and Renal Recovery. BJU International, 110, E1027-E1034. https://doi.org/10.1111/j.1464-410X.2012.11193.x</mixed-citation></ref><ref id="scirp.119725-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Natchagandé, G., Avakoudjo, J.D.G., Hounmasso, P.P., et al. (2015) Insuffisance rénale obstructive; aspects épidémiologiques et diagnostiques à propos de 51 cas au CHU de Cotonou. Médecine d’Afrique Noire, 62, 16-22.</mixed-citation></ref><ref id="scirp.119725-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Diarra, M. (2020) Aspects épidémiocliniques et thérapeutiques de l’insuffisance rénale obstructive dans le service d’urologie du CHU Pr B.S.S de Kati. Thèse Med, Université des Sciences, des Techniques et des Technologies, Bamako, 110-116.</mixed-citation></ref><ref id="scirp.119725-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Machado, M.N., Nakazone, M.A. and Maia, L.N. (2014) Acute Kidney Injury Based on KDIGO (Kidney Disease Improving Global Outcomes) Criteria in Patients with Elevated Baseline Serum Creatinine Undergoing Cardiac Surgery. Revista Brasileira de Cirurgia Cardiovascular, 29, 299-307. https://doi.org/10.5935/1678-9741.20140049</mixed-citation></ref><ref id="scirp.119725-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Organisation mondiale de la Santé (2016) Rapport de l’organisation mondiale de la santé sur le vieillissement. Organisation mondiale de la Santé, Geneva.https://apps.who.int/iris/bitstream/handle/10665/206556/9789240694842_fre.pdf</mixed-citation></ref><ref id="scirp.119725-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Calestroupat, J.P., Djelouat, T. and Costa, P. (2010) Clinical Manifestations of Urolithiasis. EMC (Elsevier Masson SAS), Paris. https://vdocuments.site/manifestations-cliniques-de-la-lithiase-urinaire.html?page=1</mixed-citation></ref><ref id="scirp.119725-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Lechevallier, E., Traxer, O. and Saussine, C. (2008) Prise en charge des calculs du rein (hors coralliforme et calice inférieur). Progrès en urologie, 18, 959-962. https://doi.org/10.1016/j.purol.2008.09.024</mixed-citation></ref><ref id="scirp.119725-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Gupta, M., Bolton, D.M., Gupta, P.N. and Stoller, M.L. (1994) Improved Renal Function Following Aggressive Treatment of Urolithiasis and Concurrent Mild to Moderate Renal Insufficiency. Journal of Urology, 152, 1086-1090. https://doi.org/10.1016/s0022-5347(17)32509-0</mixed-citation></ref><ref id="scirp.119725-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Kukreja, R., Desai, M., Patel, S.H. and Desai, M.R. (2003) Nephrolithiasis Associated with Renal Insufficiency: Factors Predicting Outcome. Journal of Endourology, 17, 875-879. https://doi.org/10.1089/089277903772036181</mixed-citation></ref><ref id="scirp.119725-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Daudon, M. (2005) épidémiologie actuelle de la lithiase rénale en France. Annales d’Urologie, 39, 209-231. https://doi.org/10.1016/j.anuro.2005.09.007</mixed-citation></ref><ref id="scirp.119725-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Prien, E.L. (1963) Composition des lithiases urinaires. Journal of Urology, 89, 917-924. https://doi.org/10.1016/S0022-5347(17)64673-1</mixed-citation></ref><ref id="scirp.119725-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Ongoiba, I. (1999) Les lithiases de l’appareil urinaire au service d’Urologie de l’H.N.P.-G. Thèse Méd, Université des Sciences, des Techniques et des Technologies de Bamako, Bamako, No. 92, 19.</mixed-citation></ref><ref id="scirp.119725-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Dembélé, Z. (2005) épidémiologie et traitement des lithiases urinaires dans le service d’urologie de l’h&amp;ocirc;pital national du Point-G. Thèse Méd, Bamako, No. 55, 95-100.</mixed-citation></ref><ref id="scirp.119725-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Keita, O. (2005) Etude de la lithiase urinaire infectée au service d’urologique du Centre Hospitalier Universitaire du Point &amp;laquo;G&amp;raquo;. Thèse de Méd, Bamako, No. 6, M.304.</mixed-citation></ref><ref id="scirp.119725-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Le Mali et les maladies tropicales négligées (MTN): Taux de couverture des traitements de masse pour les MTN-2016. https://unitingtocombatntds.org/wp-content/uploads/2018/01/Mali_fre.pdf</mixed-citation></ref><ref id="scirp.119725-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Agrawal, M.S., Aron, M. and Asopa, H.S. (1999) Endourological Renal Salvage in Patients with Calculus Nephropathy and Advanced Uraemia. BJU International, 84, 252-256. https://doi.org/10.1046/j.1464-410x.1999.00159.x</mixed-citation></ref><ref id="scirp.119725-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Roy, C. (2004) Imagerie de la lithiase urinaire: &amp;laquo; Trois en un &amp;raquo;. Annales d’Urologie, 40, 69-92. https://doi.org/10.1016/j.anuro.2006.01.007</mixed-citation></ref><ref id="scirp.119725-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Allodé, A.S., Gandaho, K.I., Hodonou, A.M., Samba, M.B., Ahoui, B.L.S., et al. (2017) Obstructive Renal Failure at the Tanguiéta Area Hospital in Benin: Aspects Epidemiological and Diagnostic. Uro’Andro (Journal of West Urology and Andrology Conference), 1, 335-340.</mixed-citation></ref><ref id="scirp.119725-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Frangos, E.E., Samii, K., Perrenoud, J.J. and Vischer, U.M. (2010) L’anémie du sujet agé: Une pathologie fréquente à ne pas banaliser. Revue Médicale Suisse, 6, 2125-2129.</mixed-citation></ref><ref id="scirp.119725-ref27"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dembélé</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>1974</year>)<article-title>La lithiase urinaire du noir africain au Mali (à propos de 36 observations)</article-title><source> Médecine d’Afrique Noire</source><volume> 21</volume>,<fpage> 69</fpage>-<lpage>71</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.119725-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Romanas, H. and Zelvys, A. (2002) Treatement of Patients with Urinary Tract Obstruction and Significant Renal Impairement. Medicina (Kaunas), 38, 30-35.</mixed-citation></ref><ref id="scirp.119725-ref29"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abaydi</surname><given-names> A. </given-names></name>,<etal>et al</etal>. (<year>2017</year>)<article-title>Insuffisance rénale aigue obstructive sur obstacle lithiasique (A propos de 52 cas)</article-title><source> These of Medicine</source><volume> 227</volume>,<fpage> 78</fpage>-<lpage>95</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.119725-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Hussain, M., Ali, B., Zafar, N., Naqvi, S.A. and Rizvi, S.A. (1997) Prediction of Renal Function Recovery in Obstructive Renal Failure Due to Stones. Journal of Pakistan Medical Association, 47, 159-161.</mixed-citation></ref><ref id="scirp.119725-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Hyams, E.S. and Shah, O.D. (2008) Risk for Renal Function Deterioration after Percutaneous Nephrolithotomy in Patients with Baseline Renal Insufficiency. Journal of Urology, 179, 432-433. https://doi.org/10.1016/S0022-5347(08)61269-0</mixed-citation></ref><ref id="scirp.119725-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Lengani, A., Coulibaly, G., Laville, M. and Zech, P. (1997) Epidémiologie de l’insuffisance rénale aigue au centre hospitalier national Yalgado ouédrago de ouagadougou (Burkinafaso). Atelier de néphrologie en Afrique subsahérienne, 22, 3-9.</mixed-citation></ref></ref-list></back></article>